Bank of New York Mellon Corp
BankPosition in SANA — Sana Biotechnology, Inc.
CIK 1390777
NEW YORK, NY
Position in SANA
as of Jun 30, 2026
· filed Aug 6, 2026
Position Value
$1,666,620
+$391,922 QoQ
Shares Held
477,542
+7.9% QoQ
Ownership
0.160%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#36
of 211 holders
Holding Since
Mar 2021
22 quarters on record
Voting authority
Sole 95%
Shared 0%
None 5%
Common Shares in SANA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Bank of New York Mellon Corp holds $4,845,290,998 across 311 Biotechnology names. SANA ranks #163 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,672,623 | $830,842,010 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
758,492 | $472,950,091 | |
| 3 | JAZZ |
Jazz Pharmaceuticals plc
|
1,578,013 | $380,253,782 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
492,071 | $148,128,128 | |
| 5 | INSM |
INSMED Inc
|
1,312,756 | $139,966,036 | |
| 6 | MRNA |
Moderna, Inc.
|
1,701,675 | $119,168,293 | |
| 7 | RVMD |
Revolution Medicines, Inc.
|
601,056 | $112,565,759 | |
| 8 | INCY |
Incyte Corp
|
972,825 | $110,279,435 |
All Filings in SANA
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,666,620 | 477,542 | Shares | Defined | 2026-08-06 | |
| 2026-03-31 | $1,274,698 | 442,604 | Shares | Defined | 2026-05-05 | |
| 2025-12-31 | $1,860,908 | 457,226 | Shares | Defined | 2026-02-10 | |
| 2025-09-30 | $1,440,096 | 405,661 | Shares | Defined | 2025-11-03 | |
| 2025-06-30 | $1,078,321 | 394,990 | Shares | Defined | 2025-08-05 | |
| 2025-03-31 | $578,016 | 344,058 | Shares | Defined | 2025-04-29 | |
| 2024-12-31 | $549,028 | 336,828 | Shares | Defined | 2025-02-04 | |
| 2024-09-30 | $1,359,997 | 326,923 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $2,357,320 | 431,744 | Shares | Defined | 2024-07-25 | |
| 2024-03-31 | $3,413,210 | 341,321 | Shares | Defined | 2024-04-25 | |
| 2023-12-31 | $1,481,087 | 363,012 | Shares | Defined | 2024-01-29 | |
| 2023-09-30 | $1,431,422 | 369,877 | Shares | Defined | 2023-10-24 | |
| 2023-06-30 | $2,200,043 | 369,135 | Shares | Defined | 2023-08-03 | |
| 2023-03-31 | $1,174,761 | 359,255 | Shares | Defined | 2023-05-09 | |
| 2022-12-31 | $1,438,420 | 364,157 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $2,229,984 | 371,664 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $1,989,968 | 309,482 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $2,935,950 | 355,442 | Shares | Defined | 2022-05-11 | |
| 2021-12-31 | $5,523,433 | 356,811 | Shares | Defined | 2022-02-11 | |
| 2021-09-30 | $7,257,699 | 322,278 | Shares | Defined | 2021-11-18 | |
| 2021-06-30 | $1,716,336 | 87,301 | Shares | Defined | 2021-08-11 | |
| 2021-03-31 | $1,643,543 | 49,105 | Shares | Defined | 2021-05-13 | |
| No filing history on record for this holder in this stock. | ||||||